MBA Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
MBA Advisors's PFE Position: Q1 2026 in Review
MBA Advisors increased its Pfizer (PFE) stake by 0.26% in Q1 2026, buying an estimated $1.52K and bringing the position to 21,855 shares worth $614K. The position accounts for 0.24% of the portfolio, ranked #74.
MBA Advisors first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.08M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- MBA Advisors held 21,855 shares of Pfizer worth $614K as of Q1 2026.
- MBA Advisors bought 57 Pfizer shares in Q1 2026, an estimated $1.52K.
- Pfizer made up 0.24% of MBA Advisors's portfolio in Q1 2026, its #74 holding.
- MBA Advisors first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
- MBA Advisors's Pfizer position peaked at $1.08M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.